DNTH
Dianthus Therapeutics, Inc. · Healthcare
Chief Accounting Officer Edward Carr sold $3.6M of Dianthus Therapeutics, Inc.
Sold$3,559,495
$81.49Price
43,682Shares
−100%Stake
What DNTH did after the filing
- The stock from Mon, Mar 16 open, $77.82
- +7.5%
- S&P 500, same days
- +6.5%
Measured over 30 trading days, to the Apr 28 close.
Traded Thu, Mar 12. Filed Fri, Mar 13, 4:30 PM ET, after the close. Returns use the Mar 16 open and the Apr 28 close. Not investment advice.